Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$7.85 - $10.68 $23,550 - $32,040
-3,000 Reduced 0.42%
712,300 $5.7 Million
Q2 2023

Aug 14, 2023

BUY
$9.23 - $11.23 $6.6 Million - $8.03 Million
715,300 New
715,300 $7.25 Million
Q2 2020

Aug 13, 2020

SELL
$7.75 - $22.61 $1.29 Million - $3.77 Million
-166,940 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$5.39 - $18.33 $1.26 Million - $4.27 Million
-233,060 Reduced 58.27%
166,940 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$11.26 - $13.8 $4.5 Million - $5.52 Million
400,000 New
400,000 $5.18 Million

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $51.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.